SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001522767-24-000005
Filing Date
2024-03-06
Accepted
2024-03-06 17:06:10
Documents
16
Period of Report
2024-03-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrmd-20240306.htm   iXBRL 8-K 24826
2 EX-99.1 marimedq42023ex991.htm EX-99.1 308315
6 picture2.jpg GRAPHIC 8155
  Complete submission text file 0001522767-24-000005.txt   481923

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrmd-20240306.xsd EX-101.SCH 1898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrmd-20240306_lab.xml EX-101.LAB 20311
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrmd-20240306_pre.xml EX-101.PRE 11505
17 EXTRACTED XBRL INSTANCE DOCUMENT mrmd-20240306_htm.xml XML 2512
Mailing Address 10 OCEANA WAY 2ND FLOOR NORWOOD MA 02062
Business Address 10 OCEANA WAY 2ND FLOOR NORWOOD MA 02062 781-277-0007
MARIMED INC. (Filer) CIK: 0001522767 (see all company filings)

IRS No.: 274672745 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54433 | Film No.: 24726895
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)